Sector News

Medtronic names former Amazon robotics VP as technology chief

June 11, 2023
Life sciences

Medtronic has named Ken Washington, former vice president and general manager of consumer robotics at Amazon, to the newly created position of chief technology and innovation officer for the device maker.

Washington will become a member of Medtronic’s executive committee.

He brings extensive experience leading technology development and execution across industries including robotics, consumer products, automotive and space, and will be tasked with accelerating innovation-driven growth, Medtronic said.

“His hiring seems to fit into the larger pattern that [Medtronic CEO] Geoff Martha has established – looking widely outside of medtech for individuals with deep, functional expertise and bringing them over. For instance, Greg Smith joined to lead MDT’s supply chain and he came from Walmart. Que Dallara brought significant software experience from Honeywell’s aeronautics business over to MDT’s diabetes segment,” Morningstar analyst Debbie Wang said in an email. READ MORE

By Susan Kelly


comments closed

Related News

June 8, 2024

Lilly CFO leaves to join Alphabet

Life sciences

Anat Ashkenazi will leave Eli Lilly’s executive suite at the end of July to become CFO and senior vice president of Google and Alphabet. Ashkenazi has been CFO at Lilly since 2021 and originally joined the company in 2001. Over her 23-year career at the Indianapolis-based drugmaker, Ashkenazi also served as controller, CFO of Lilly Research Laboratories and as the finance chief for several global divisions within the company.

June 8, 2024

Edwards Lifesciences to cell Critical Care to BD

Life sciences

Edwards Lifesciences (NYSE: EW) announced it has entered into a definitive agreement to sell its Critical Care product group to BD (Becton, Dickinson and Company), in an all-cash transaction valued at $4.2 billion. With this agreement, Edwards is no longer pursuing the previously announced spin-off of Critical Care.

June 8, 2024

Danaher names Martin Stumpe as chief data and AI officer

Life sciences

The company, which owns diagnostics and life sciences businesses including Beckman Coulter and Cepheid, said the appointment reflects its increasing investment in AI as “a driving force for innovation and productivity.” Danaher is focused on AI by also spending on its internal capabilities and partnering with academic groups.

How can we help you?

We're easy to reach